
Here’s why the Mereo BioPharma Group PLC (MREO) Stock Gained Momentum in the Pre Market
Mereo BioPharma Group PLC (MREO) is leading oncology and rare diseases-related biopharmaceutical company. The main product candidate of the company is etigilimab (OMP-313M32) for the